Provided by Tiger Trade Technology Pte. Ltd.

GoodRx Holdings, Inc.

3.35
+0.01000.30%
Post-market: 3.350.00000.00%19:30 EDT
Volume:971.64K
Turnover:3.24M
Market Cap:1.14B
PE:70.58
High:3.37
Open:3.30
Low:3.28
Close:3.34
52wk High:5.81
52wk Low:1.77
Shares:341.15M
Float Shares:93.97M
Volume Ratio:0.82
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0475
EPS(LYR):0.0854
ROE:2.52%
ROA:3.05%
PB:1.76
PE(LYR):39.22

Loading ...

GoodRx Holdings Inc - Ozempic Pill Priced at $149 (1.5Mg), $199 (4Mg), $299 (9Mg) per Month

THOMSON REUTERS
·
May 01

GoodRx Expands Offerings to NOW Include Ozempic® Pill for Type 2 Diabetes Patients

THOMSON REUTERS
·
May 01

GoodRx publishes 2025 annual report

Reuters
·
May 01

GoodRx names Thomas Chan chief accounting officer

Reuters
·
Apr 25

GoodRx sets first-quarter earnings release, conference call

Reuters
·
Apr 18

GoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market

Benzinga_recent_news
·
Apr 16

GoodRx Offering Novo Nordisk's Wegovy HD Weight Loss Drug

MT Newswires Live
·
Apr 15

GoodRx NOW Offers Access to Wegovy® Hd at $399 per Month Self-Pay Price

THOMSON REUTERS
·
Apr 15

Broadridge Financial Solutions Inc. Stock Falls To New 52-Week Low

Dow Jones
·
Apr 11

BUZZ-U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman

Reuters
·
Apr 10

What's Going On With GoodRx Stock Thursday?

Benzinga_recent_news
·
Apr 09

BUZZ-GoodRx rises after offering Lilly weight-loss drugs at discounted self-pay prices

Reuters
·
Apr 09

GoodRx Shares Rise 5.1% Premarket After Co Says Will Offer Self-Pay Access to Eli Lilly's New Weight-Loss Pill

THOMSON REUTERS
·
Apr 09

GoodRx partners with Eli Lilly to offer Foundayo self-pay pricing from $149 monthly

Reuters
·
Apr 09

GoodRx Expands Access to Eli Lilly and Company’s New Oral Glp-1, Foundayo™, and Zepbound® Kwikpen® With Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide

THOMSON REUTERS
·
Apr 09

3 Promising Penny Stocks With Market Caps Under $2B

Simply Wall St.
·
Apr 06

GoodRx Reshapes Board After Director Resignation and Reclassification

TIPRANKS
·
Apr 04

GoodRx director Ian Clark resigns from board, effective March 31

Reuters
·
Apr 04

Barclays Keeps Their Sell Rating on GoodRx Holdings (GDRX)

TIPRANKS
·
Mar 30

GoodRx announces resignation of Chief Accounting Officer Romin Nabiey

TIPRANKS
·
Mar 28